Figure 4
Figure 4. Early posttransplant Tc17 cells express altered T-cell memory markers and reduced CTL effector molecules. Phenotypic analysis of splenic CD8+YFP+ and CD8+YFPneg T cells d7 posttransplant (B6.IL-17CreRosa26eYFP→B6D2F1). (A-D) Representative flow cytometry analysis of markers associated with (A) T-cell activation, (B) T-cell memory, (C) specialized T-cell functions and chemokine/cytokine receptor expression, and (D) CTL effector function. CD8+YFP+ (filled dark gray), CD8+YFPneg (thick black), isotype (thin dashed), positive control cells (filled light gray), CD8+YFP+IL-17+ (thick gray), and CD8+YFP+IL-17neg (black dotted). (E) Quantitative analysis of Granzyme B, Ly6C, IL-10R, FasL, and CD107a expression in CD8+ T cells (mean ± SEM, n = 5-6 mice/group; **P < .01). (C) Positive controls used: γδ TCR+ CD4–CD8– naïve T cells, NK1.1+ naïve NK cells, NKT tetramer+CD4+ naïve NKT-cells, MR1 tetramer+CD4–CD8– naïve T cells, and CD40L+CD4+ naïve T-cells.

Early posttransplant Tc17 cells express altered T-cell memory markers and reduced CTL effector molecules. Phenotypic analysis of splenic CD8+YFP+ and CD8+YFPneg T cells d7 posttransplant (B6.IL-17CreRosa26eYFP→B6D2F1). (A-D) Representative flow cytometry analysis of markers associated with (A) T-cell activation, (B) T-cell memory, (C) specialized T-cell functions and chemokine/cytokine receptor expression, and (D) CTL effector function. CD8+YFP+ (filled dark gray), CD8+YFPneg (thick black), isotype (thin dashed), positive control cells (filled light gray), CD8+YFP+IL-17+ (thick gray), and CD8+YFP+IL-17neg (black dotted). (E) Quantitative analysis of Granzyme B, Ly6C, IL-10R, FasL, and CD107a expression in CD8+ T cells (mean ± SEM, n = 5-6 mice/group; **P < .01). (C) Positive controls used: γδ TCR+ CD4CD8 naïve T cells, NK1.1+ naïve NK cells, NKT tetramer+CD4+ naïve NKT-cells, MR1 tetramer+CD4CD8 naïve T cells, and CD40L+CD4+ naïve T-cells.

Close Modal

or Create an Account

Close Modal
Close Modal